News

prof. Christian Hengstenberg and prof. Julia Mascherbauer at FNUSA-ICRC

12. 9. 2019 | 

Following last year's visit of the Heads of Cardiology Research Teams of the International Clinical Research Center of St. Anne's University Hospital Brno (FNUSA-ICRC) at the University of Medicine and the General Hospital in Vienna Prof. Christian Hengstenberg - Head of the Department of Cardiology and his colleague Professor Julia Mascherbauer - Head of the Department of Cardiovascular Magnetic Resonance, arrived on September 11.

The visit to the laboratories of cardiology research teams was followed by public lectures. Professor Hengstenberg spoke about his experience with Transcatheter Aortic Valve Implantation (TAVI) in a lecture entitled Modern Therapy of Valvular Heart Disease. Professor Mascherbauer followed up with a presentation entitled Mitral and Tricuspid Valves.

One of the points of the visit program was also the establishment of cooperation between the 1st Department of Internal Cardio-angiology (I. IKAK) of the of St. Anne's University Hospital Brno in Brno and the Clinic of Cardiology of the General Hospital in Vienna. “Cooperation with the workplace in Vienna seems to be very promising for us,” added prof. MUDr. Lenka Špinarová, Ph.D, FESC, head of I. IKAK.

Prof. Christian Hengstenberg and Professor Julia Mascherbauer  at FNUSA-ICRC
NY Times Cover Page

11. 9. 2019

Úvodní strana New York Times

With a little exaggeration, it could be written like that. Information that the scientists from the International Clinical Research Center of St. Anne's University Hospital Brno (FNUSA-ICRC) contributed significantly to research that has shown that dog owners are healthier than the rest of the population, most Czech media have taken over.

Now the report has been published by Mayo Clinic scientists in their Mayo Clinic Proceedings magazine, and US news sites have also shown great interest in this information. Brno was thus mentioned in such influential and well-known American media as CNN television, the New York Times, or the Newsweek weekly. See the list of media channels below:

CNN: https://edition.cnn.com/2019/08/23/health/dog-study-heart-healthy-trnd/index.html
New York Times https://www.nytimes.com/2019/08/26/well/family/dogs-cats-pets-heart-health.html
NewsWeek https://www.newsweek.com/owning-dog-boost-heart-health-scientists-1455648
New York Post https://nypost.com/2019/08/23/want-a-healthy-heart-get-a-dog-study-suggests/

Thanks to Kardiovize Brno 2030 group for spreading awareness about our city!

ICoLA 2019 Logo

9. 9. 2019 |

ICoLA 2019

Cardiovascular experts met in the capital of the Republic of Korea for three days. For the eighth time, the International Congress of Lipids and Atherosclerosis (ICoLA 2019) was attended by nearly a thousand delegates and fifty exhibiting companies. It was a unique opportunity to exchange scientific knowledge on cardiometabolic risk, to share knowledge and research results through active discussions, and to network with one another.

The International Clinical Research Center of St. Anne's University Hospital Brno (FNUSA-ICRC) was actively represented by Manlio Vinciguerra, head of the research team Epigenetics, Metabolism and Aging. "I spoke at a blood pressure symposium with a presentation on Anti-hypertensive Effects of FMD (Fasting Mimicking Diet) and Cardiovascular Disease on Friday," added Manlio Vinciguerra. "On Saturday I chaired an interesting session on Air Pollution and Cardiovascular Disease.”

Let's just add that the Fast Mimicking Diet is called an imitation of a five-day fast. It is a low-calorie five-day diet program designed to promote weight loss and provide the same benefits as traditional fasting methods. Several clinical studies have shown that in addition to weight loss, it also lowers blood sugar, cholesterol, and helps with inflammatory problems.
 

The International Human Peroxidase Meeting  Brno

6. 9. 2019 | 

The International Human Peroxidase Meeting is now taking place in Brno. It is the world's most important event for mammalian peroxidase researchers and its role in human health or disease identification. The meeting is organized by the The International Clinical Research Center of St. Anne's University Hospital Brno (FNUSA-ICRC) together with the Institute of Biophysics of the Academy of Sciences of the Czech Republic and the Universität für Bodenkultur Wien (BOKU).

Peroxidases are a large group of enzymes that play a role in various biological processes. "This conference focuses mainly on myeloperoxidase, eosinophil peroxidase, lactoperoxidase, thyroid peroxidase, peroxidazines 1 & 2, therefore heme peroxidase in mammals," confirmed Lukáš Kubala, head of the FNUSA-ICRC research team Inflammation. "The topics will cover both the molecular enzymology, physiology and pathophysiology of peroxidases, the chemistry and biochemistry of oxidation products, and the function of peroxidases in host defense and tissue biology."

Participators were welcomed also by Christine Winterbourn, a world-renowned legend in the field. She came to Brno from the University of Otago (New Zealand), where she is a professor of pathology. She was one of the first scientists to prove that human cells produce free radicals as part of their normal function and have documented some of the free radical chemical reactions that occur in diseases such as cancer, stroke, ischemic heart disease or arthritis. As the first woman in history she has received the Rutherford Medal, the most prestigious scientific award in New Zealand.

Christine Winterbourn in Brno, University in Otago
Nadační fond Roeselové - logo

2. 9. 2019

Nadační fond Martiny Roeselové - logo

Until 30 September 2019, it is possible to apply for a grant from Martina Roeselová Endowment Fund, which is awarded for one calendar year, in the total amount of CZK 120,000. Applications are open to Ph.D. students and postdoctoral researchers caring for a preschool child or children while actively pursuing a career in natural sciences at a university or at a non-university research organization in the Czech Republic. 

Last year, MD Petra Šedová received this grant.

More info
Caver PyMOL logo

29. 8. 2019 | 

Loschmidt Laboratories announced a new version of CAVER PyMOL plugin. Bioinformatics from the FNUSA-ICRC Protein Engineering Research Team contributed to this result.

CAVER is a software tool for analysis and visualization of tunnels and channels in protein structures. Tunnels are void pathways leading from a cavity buried in a protein core to the surrounding solvent. Unlike tunnels, channels lead through the protein structure and their both endings are opened to the surrounding solvent. Studying of these pathways is highly important for drug design and molecular enzymology. It is a popular software with more than one hundred and eleven thousand downloads.

"The new version of the plugin is now compatible with the latest version of PyMOL 3.0," confirmed Jiří Damborský. “It has several enhancements for easier installation and a more user-friendly experience. The ease-of-use and user-friendliness of the new software is key to us. We develop and provide software tools to the professional community within the ELIXIR project.”

CAVER software logo
Go to top